record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to staterecord state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundtheoretical · manual state transition
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition
evidence type
theoretical
conditions
Provenance
source title
Real-world compassionate use data, Gustave Roussy, 2024
authors
reviewer:will-blair
Reirradiation at time of ONC201 initiation is associated with significantly longer overall survival after drug start in pediatric patients (n=102 children in compassionate use cohort), but effect modest in adults; median OS after ONC201 4.7 months overall.
vs_01ed2dd05fbeac94 · manual_curation
outgoing
vf_8ec3f30b3e4aada4Reirradiation benefit in pediatric cohort conflicts with baseline OS deficit in children
incoming
supports · vf_b9d6c5c40b15e0c2
replicates · vf_625d02b86fe9f0da
events
vev_80302dc448d366f5finding.assertedManual finding added to frontier state
reviewer:will-blair · 2026-05-29
reviewable changes
vpr_19f57d3de6297649finding.addManual finding added to frontier state
applied · reviewer:will-blair · 2026-05-29
evaluations
No evaluation record targets this finding id.